New combo therapy aims to tame throat cancer with fewer side effects
Disease control
Not yet recruiting
This study tests whether a new drug (ATRN-119) combined with a single, precise dose of radiation is safe and effective for early-stage HPV-positive throat cancer. About 35 adults will take the drug daily for 10 days and receive one radiation treatment, followed by standard surger…
Phase: PHASE1, PHASE2 • Sponsor: John Lukens • Aim: Disease control
Last updated May 13, 2026 16:01 UTC